White Paper by Stuart Diamond
OPTIMAL TRUST INDEX: Pharma/Biotech
Summary: Trust is the invisible currency of the pharmaceutical and biotech industries—powering everything from investor confidence to patient compliance, yet it is rarely measured with the same precision as clinical efficacy or earnings per share. Amid growing public skepticism, political scrutiny, and market volatility, understanding and quantifying trust is no longer optional—it's strategic.Trust is the invisible currency of the pharmaceutical and biotech industries—powering everything from investor confidence to patient compliance, yet it is rarely measured with the same precision as clinical efficacy or earnings per share. Amid growing public skepticism, political scrutiny, and market volatility, understanding and quantifying trust is no longer optional—it's strategic.
The Optimal Trust Index (OTI) provides a first-of-its-kind framework to track and analyze trust across key stakeholder groups: investors, patients, and medical professionals. By scoring six core trust components across three levels—individual, organizational, and sector-wide—the OTI sheds light on how trust shapes decision-making and market outcomes. This white paper introduces the Pharma-Biotech Trust Index, a tool designed not only to monitor sentiment and perception, but also to anticipate market behavior with surprising accuracy.
